Diffusion tensor magnetic resonance imaging of disruption of regional white matter in schizophrenia

Neuropsychobiology

Volumn 47, Issue 3, 2003, Pages 141-145

  Minami, Tomohisa ^a   Nobuhara, K ^a   Okugawa, G ^a   Takase, K ^a   Yoshida, T ^a   Sawada, S ^a   Ha Kawa, S ^a   Ikeda, K ^a   Kinoshita, T ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Anisotropy; Diffusion tensor imaging; Schizophrenia; White matter

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ANISOTROPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FRONTAL LOBE; HUMAN; MALE; PRIORITY JOURNAL; SCALE UP; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; WHITE MATTER;

ADULT; ANISOTROPY; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 0038316676     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070583     Document Type: Article

References (26)

1. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H: Diffusion tensor imaging: Concepts and applications. J Magn Reson Imaging 2001;13:534-546.
2. Makris N, Worth AJ, Sorensen AG, Papadimitriou GM, Wu O, Reese TG, Wedeen VJ, Davis TL, Stakes JW, Caviness VS, Kaplan E, Rosen BR, Pandya DN, Kennedy DN: Morphometry of in vivo human white matter association pathways with diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;42:951-962.
3. Wimberger DM, Roberts TP, Barkovich AJ, Prayer LM, Moseley ME, Kucharczyk J: Identification of 'premyelination' by diffusion-weighted MRI. J Comput Assist Tomogr 1995;19:28-33.
4. Nakada T, Matsuzawa H: Three-dimensional anisotropy contrast magnetic resonance imaging of the rat nervous system: MR axonography. Neurosci Res 1995;22:389-398.
5. Basser PJ, Mattiello J, LeBihan D: Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994;103:247-254.
6. Moseley ME, Cohen Y, Kucharczyk J, Minto-rovitch J, Asgari HS, Wendland MF, Tsuruda J, Norman D: Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990;176:439-445.
7. Werring DJ, Clark CA, Parker GJ, Miller DH, Thompson AJ, Barker GJ: A direct demonstration of both structure and function in the visual system: Combining diffusion tensor imaging with functional magnetic resonance imaging. Neuroimage 1999;9:352-361.
8. Beaulieu C, Allen PS: Determinants of anisotropic water diffusion in nerves. Magn Reson Med 1994;31:394-400.
9. McCarley RW, Wible CG, Frumin M, Hi-rayasu Y, Levitt JJ, Fischer IA, Shenton ME: MRI anatomy of schizophrenia. Biol Psychiatry 1999;45:1099-1119.
10. Wible CG, Anderson J, Shenton ME, Kricun A, Hirayasu Y, Tanaka S, Levitt JJ, O'Donnell BF, Kikinis R, Jolesz FA, McCarley RW: Pre-frontal cortex, negative symptoms, and schizophrenia: An MRI study. Psychiatry Res 2001;108:65-78.
11. Hulshoff Pol HE, Schnack HG, Bertens MG, van Haren NE, van der Tweel I, Staal WG, Baare WF, Kahn RS: Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry 2002;159:244-250.
12. Buchsbaum MS: The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull 1990;16:379-389.
13. Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, Doo M, Jin Y, Wu JC, Fallon JH: A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatry 2002;159:227-237.
14. Lawrie SM, Buechel C, Whalley HC, Frith CD, Friston KJ, Johnstone EC: Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol Psychiatry 2002;51:1008-1011.
15. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, McDowell J, Braff DL: Parietal dysfunction is associated with increased outcome-related decision-making in schizophrenia patients. Biol Psychiatry 2002;51:995-1004.
16. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A: Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 1999;56:367-374.
17. Foong J, Maier M, Clark CA, Barker GJ, Miller DH, Ron MA: Neuropathological abnormalities of the corpus callosum in schizophrenia: A diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 2000;68:242-244.
18. Kubicki M, Westin CF, Maier SE, Frumin M, Nestor PG, Salisbury DF, Kikinis R, Jolesz FA, McCarley RW, Shenton ME: Uncinate fasciculus findings in schizophrenia: A magnetic resonance diffusion tensor imaging study. Am J Psychiatry 2002;159:813-820.
19. Hoptman MJ, Volavka J, Johnson G, Weiss E, Bilder RM, Lim KO: Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: A preliminary study. Biol Psychiatry 2002;52:9-14.
20. Agartz I, Andersson JL, Skare S: Abnormal brain white matter in schizophrenia: A diffusion tensor imaging study. Neuroreport 2001;12:2251-2254.
21. Buchsbaum MS, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA, Downhill J, Haznedar M, Fallon JH, Atlas SW: MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 1998;9:425-430.
22. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA: Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001;98:4746-4751.
23. Tauscher J, Fischer P, Neumeister A, Rappelsberger P, Kasper S: Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients. Biol Psychiatry 1998;44:438-447.
24. Hirayasu Y, Potts GF, O'Donnell BF, Kwon JS, Arakaki H, Akdag SJ, Levitt JJ, Shenton ME, McCarley RW: Auditory mismatch negativity in schizophrenia: Topographic evaluation with a high-density recording montage. Am J Psychiatry 1998;155:1281-1284.
25. Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW: Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry 1997;154:688-690.
26. Jarema M, Choma M, Poniatowska R, Krawczyk R, Kozlowski P: Improvement criteria after neuroleptic treatment and clinical and neuroradiological factors in schizophrenic psychoses. Preliminary studies. Psychiatr Pol 1997;31:21-32.